Year |
Citation |
Score |
2008 |
Knapp PE, Rizzo JP, Alimova Y, Singh I, Goody RJ, Hauser KF. Glutamatergic effects of dynorphin peptides on cultured oligodendrocytes Journal of Neurochemistry. 81: 46-48. DOI: 10.1046/J.1471-4159.81.S1.15_4.X |
0.588 |
|
2006 |
Woods AS, Kaminski R, Oz M, Wang Y, Hauser K, Goody R, Wang HY, Jackson SN, Zeitz P, Zeitz KP, Zolkowska D, Schepers R, Nold M, Danielson J, Gräslund A, et al. Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity. Journal of Proteome Research. 5: 1017-23. PMID 16602711 DOI: 10.1021/Pr060016+ |
0.549 |
|
2004 |
Singh IN, Goody RJ, Dean C, Ahmad NM, Lutz SE, Knapp PE, Nath A, Hauser KF. Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G. Journal of Neurovirology. 10: 141-51. PMID 15204919 DOI: 10.1080/13550280490441103 |
0.535 |
|
2003 |
Singh IN, Goody RJ, Goebel SM, Martin KM, Knapp PE, Marinova Z, Hirschberg D, Yakovleva T, Bergman T, Bakalkin G, Hauser KF. Dynorphin A (1-17) induces apoptosis in striatal neurons in vitro through alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor-mediated cytochrome c release and caspase-3 activation. Neuroscience. 122: 1013-23. PMID 14643768 DOI: 10.1016/J.Neuroscience.2003.08.033 |
0.607 |
|
2003 |
Hauser KF, Khurdayan VK, Goody RJ, Nath A, Saria A, Pauly JR. Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability. Cerebellum (London, England). 2: 184-95. PMID 14509568 DOI: 10.1080/14734220310016132 |
0.475 |
|
2003 |
Goody RJ, Martin KM, Goebel SM, Hauser KF. Dynorphin A toxicity in striatal neurons via an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor mechanism. Neuroscience. 116: 807-16. PMID 12573721 DOI: 10.1016/S0306-4522(02)00563-8 |
0.612 |
|
2001 |
Goody RJ, Kitchen I. Influence of maternal milk on functional activation of delta-opioid receptors in postnatal rats. The Journal of Pharmacology and Experimental Therapeutics. 296: 744-8. PMID 11181901 |
0.312 |
|
Show low-probability matches. |